March 22, 2018 / 8:20 PM / in 7 months

BRIEF-La Jolla PharmaAnnounces Launch Of Giapreza In United States

March 22 (Reuters) - La Jolla Pharmaceutical Co:

* LA JOLLA PHARMACEUTICAL COMPANY ANNOUNCES LAUNCH OF GIAPREZA™ (ANGIOTENSIN II) IN THE UNITED STATES

* LA JOLLA PHARMACEUTICAL CO - GIAPREZA IS AVAILABLE IN 1 ML SINGLE-DOSE VIALS, EACH CONTAINING 2.5 MG OF ANGIOTENSIN II Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below